Abstract | OBJECTIVE: METHODS: Three hundred patients with hyperlipidemia were randomly divided adopting numerical table method into 7 groups, the Taizhi'an group (A, n = 90), the half-dose Fenofibrate plus Taizhi'an group (B, n = 30), the full-dose Fenofibrate group (C, n = 30), the half-dose Simvastatin plus Taizhi'an group (D, n = 30), the full-dose Simvastatin group (E, n = 30), the Zhibituo group (F, n = 60) and the Xuezhikang group (G, n = 30). The effect in different groups were compared after 8 weeks treatment. RESULTS: CONCLUSION:
|
Authors | Qing-lang Li, Yue-fei Zhang |
Journal | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
(Zhongguo Zhong Xi Yi Jie He Za Zhi)
Vol. 23
Issue 5
Pg. 335-7
(May 2003)
ISSN: 1003-5370 [Print] China |
PMID | 12800412
(Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anticholesteremic Agents
- Capsules
- Drugs, Chinese Herbal
|
Topics |
- Adult
- Aged
- Anticholesteremic Agents
(therapeutic use)
- Capsules
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Humans
- Hyperlipidemias
(drug therapy)
- Male
- Middle Aged
- Phytotherapy
|